Pharma Sector

Index
  • 1m
  • 6m
  • ytd
  • 1y
  • 3y
  • 5y
  • max
Constituents (235 Companies)
Company Name
PE
Market Cap (Cr.)
M.Cap (Cr.)
39.81
4,56,989
74.55
1,61,290
30.37
1,17,820
27.34
1,14,730
22.58
1,13,815
21.23
1,13,215
54.65
1,04,535
26.60
93,217
180
69,466
28.94
66,606
45.79
62,362
35.39
54,930
39.59
45,182
39.35
41,550
39.13
40,535
53.48
37,944
37.70
34,846
147
31,497
87.32
21,545
28.91
20,885
110
20,745
34.70
20,645
32.03
19,844
30.05
19,272
-
19,131
52.86
17,029
11.78
16,704
23.96
16,169
51.33
13,391
72.50
12,853
67.27
12,453
30.56
12,257
28.63
11,964
48.91
11,902
41.34
10,662
32.30
10,560
18.68
10,387
44.91
9,864
38.62
9,856
56.60
9,786
-
8,647
25.47
7,890
5.00
7,761
25.06
7,054
55.10
6,356
38.84
5,474
41.57
5,368
-
5,004
236
4,854
90.17
4,209
30.51
4,199
34.70
3,997
38.71
3,948
61.06
3,921
21.12
3,564
18.07
3,522
-
3,366
13.18
3,332
34.07
3,232
41.23
2,777
192
2,738
7.51
2,383
55.87
2,318
22.28
2,289
-
2,257
40.83
1,965
61.95
1,889
33.77
1,879
44.95
1,861
27.07
1,799
36.07
1,554
26.80
1,552
43.75
1,427
63.17
1,393
17.50
1,338
23.99
1,337
19.79
1,300
43.26
1,254
14.13
1,242
27.31
1,198
54.46
1,161
953
1,091
14.18
1,018
23.35
1,003
42.31
986
-
954
36.51
939
48.71
865
29.41
860
30.31
843
19.58
804
33.93
697
21.95
662
112
659
43.09
641
26.70
537
29.15
530
47.00
522
29.05
503
14.18
493
22.95
470
-
411
86.83
401
71.71
356
36.86
355
-
350
25.94
340
35.25
319
16.62
317
27.36
296
-
280
59.62
269
47.35
263
-
260
14.08
251
11.77
247
61.55
244
13.55
234
-
232
-
230
9.31
229
44.62
220
105
219
13.21
216
18.32
200
10.09
198
105
192
28.05
190
36.28
184
-
177
24.45
177
17.97
176
17.90
173
660
171
14.27
168
12.67
165
-
161
44.98
159
10.36
156
14.36
155
20.54
153
28.45
144
9.60
144
38.61
132
21.54
131
18.71
130
-
128
31.59
126
30.71
126
19.80
124
-
123
65.79
119
20.12
116
12.69
107
96.72
102
24.00
98
19.74
95
23.65
95
38.01
89
22.25
88
7.29
83
11.66
81
-
81
22.51
77
-
75
37.63
73
-
72
3.86
68
-
65
119
65
16.30
63
36.78
57
19.88
55
10.96
54
-
52
5.38
49
15.44
49
11.41
48
-
48
19.70
46
-
45
-
45
-
45
-
45
99.65
44
9.88
41
19.80
40
25.89
40
87.13
39
473
39
-
38
13.28
33
5.21
33
10.58
32
26.12
32
-
31
51.09
31
12.18
30
-
30
-
29
8.12
28
4.70
28
11.81
26
30.90
26
18.24
23
-
23
88.82
22
28.13
22
-
21
38.08
20
-
20
-
20
32.99
19
142
17
3,321
17
-
15
-
14
-
13
8.20
13
157
12
-
12
27.98
12
25.32
11
11.79
8
-
8
-
7
-
7
89.76
7
83.79
7
-
7
-
5
69.81
4
-
4
-
3
-
2
Showing 5 235 of 235 Show More
Market Share

    Select a Metric
    • Gastrointestinal (Nurokind-LC) - Market Share (%)
    • Fermentation Based API Products - Market Share (%)
    • Depression (Placida) - Market Share (%)
    • Birth Control (Unwanted-72) - Market Share (%)
    • Anti Fungal Antibiotics (Terbinaforce) - Market Share (%)
    • Anti-Hypertensives (Amolkind-AT) Market Share (%)
    • Gastro-Intestinal - Market Share (%)
    • Vaccines - Market Share (%)
    • Sex Stimulants - Market Share (%)
    • Pharmaceutical Sector - Market Share (%)
    • Cardiovascular - Market Share (%)
    • Vitamin & Dietary Supplements - Market Share (%)
    • Anti - Diabetes - Market Share (%)
    • Anti-Infectives - Market Share (%)
    Operational Metrics

    Select a Metric
    • Pharma spend as a % of GDP - India (%)
    • Pharma spend as a % of GDP - Korea (%)
    • Pharma spend as a % of GDP - USA (%)
    • Domestic Pharma - Monthly Sales (Crs)
    • Domestic Pharma Price Growth (%)
    • Domestic Pharma Volume Growth (%)
    • Total ANDA's Approved by USFDA

      Select a Metric
      • Fermentation Capacity (KL)
      • No Of Pharmacies (.)
      • Number of ANDA's Approved By USFDA (.)
      • Number of ANDA's Filed in USA (.)
      • Manufacturing Capacity - Metformin (MTPA)
      • No of Pharmacy Outlets - Kolkata (.)
      • Quarterly Sales Volume - Injectables (Nos)
      • Quarterly Sales Volume - Nutraceuticals (Nos)
      • Quarterly Sales Volume - Orals (Nos)
      • Realization / Tonne - Piperazine (Rs/MT)
      • Manufacturing Capacity - Pyridin-3-One (MTPA)
      • Realization / Tonne - Pyridin-3-One (Rs/MT)
      • Domestic Sales Growth - YoY (%)
      • Number of ANDA's Approved (.)
      • Number of ANDA's Filed in Europe
      • Number of ANDA's Approved in Europe
      • Canada DMF fillings (.)
      • US DMF Filings (.)
      • Australia DMF fillings (.)
      • US DMF Approval (.)
      • Europe DMF Filings (.)
      • DMF Filingsby API (.)
      • Total reactor capacity (kL)
      • Global DMFs filed (.)
      • APIs Production Capacity (MTPA)
      • Japan DMF Filings (.)
      • Capacity Utilization - Benzimidazole (%)
      • Realization - Tetralone (Rs/Tonne)
      • Manufacturing Capacity - Omeprazole (MTPA)
      • Capacity Utilization - Esomeprazole (%)
      • Realization - Pantaprazole Sodium (Rs/Tonne)
      • Capacity Utilization - Omeprazole (%)
      • Manufacturing Capacity - Benzimidazole (MTPA)
      • Realization - Chloro Compound (Rs/Tonne)
      • Manufacturing Capacity - Pantaprazole (MTPA)
      • Realization - Op. Sulphide (Rs/Tonne)
      • Realization - Esomeprazole Magnesium (Rs/Tonne)
      • Capacity Utilization - Chloro Compound (%)
      • Capacity Utilization - Pantaprazole (%)
      • Realization - Benzimidazole (Rs/Tonne)
      • Realization - Omeprazole Powder (Rs/Tonne)
      • Manufacturing Capacity - Esomeprazole (MTPA)
      • Manufacturing Capacity - Chloro Compound (MTPA)
      • Realization - Ammonium Sulphate (Rs/Tonne)
      • Manufacturing Capacity - Ibuprofen (MTPA)
      • Capacity Utilization - Pharmaceuticals (%)
      • Number of ANDA's Filed in Canada
      • Number of ANDA's Approved by Canada
      • Number of ANDA's Filed in Australia
      • Number of ANDA's Approved by Australia
      • Number of ANDA's Filed in South Africa
      • Number of ANDA's Approved by South Africa
      • Number of ANDA's Filed in Latam
      • Number of ANDA's Approved by Latam
      • Manufacturing Capacity - Piperazine (MTPA)
      • Manufacturing Capacity - Paracetamol (MTPA)
      • No of Pharmacy Outlets - Hyderabad (.)
      • No of Pharmacy Outlets - Bangalore (.)
      • No of Pharmacy Outlets - Chennai (.)
      Segments

      Select a Metric
      • Therapeutic wise Break-Up - Domestic Pharma (Crs)
      • Dermatology (Crs)
      • Cardiovascular (Crs)
      • Blood Related (Crs)
      • Antineo Plastic (Crs)
      • Anti-Malarial (Crs)
      • Anti - Infectives (Crs)
      • Vaccines (Crs)
      • Stomatological (Crs)
      • Sex Stimulants (Crs)
      • Respiratory (Crs)
      • Pain (Crs)
      • Others (Crs)
      • Ophthalmology (Crs)
      • Neurological (Crs)
      • Gynecology (Crs)
      • Gastro-Intestinal (Crs)
      • Endocrinology (Crs)
      • Urology (Crs)
      • Vitamin & Dietary Supplements (Crs)
      • Anti - Diabetes (Crs)
      • Indian vs MNC - Domestic Share (Crs)
      • Indian (Crs)
      • MNC (Crs)
      Export Import Data

      • 1y
      • 2y
      • 3y
      • 5y
      • 10y
        Select a Metric
        • Pharmaceutical Products (Kgs)
        Ideas Dashboard
        Results
        Timeline
        Watchlist
        Portfolio
        Alerts
        Stock Screener
        Market
        Raw Material